Literature DB >> 11278110

A functional role for adenosine A3 receptors: modulation of synaptic plasticity in the rat hippocampus.

A R Costenla1, L V Lopes, A de Mendonça, J A Ribeiro.   

Abstract

Adenosine modulates hippocampal synaptic plasticity, namely long-term potentiation (LTP) and long-term depression (LTD), through activation of A1 and A2A receptors. We now report a novel role for the recently described adenosine A3 receptor in the regulation of synaptic plasticity in the CA1 area of hippocampal slices. Activation of adenosine A3 receptors by (1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-p-yl]-1-deoxy-N-methyl-beta-D-ribofuranuronamide (Cl-IBMECA) (100 nM) increased the magnitude of theta-burst induced LTP (from 1.2+/-0.6% in the control solution to 25.5+/-0.8% in the presence of Cl-IBMECA) and attenuated LTD (from 30.0+/-5.5% decrease in the control solution to 13.6+/-6.6% decrease in the presence of Cl-IBMECA). The selective adenosine A3 receptor antagonist, MRS 1191 (5-10 microM), prevented the effects of Cl-IBMECA. These findings indicate a functional role for adenosine A3 receptors in the modulation of synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278110     DOI: 10.1016/s0304-3940(01)01633-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro.

Authors:  Anna Maria Pugliese; Elisabetta Coppi; Giampiero Spalluto; Renato Corradetti; Felicita Pedata
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

3.  Adenosine A(3) receptors regulate heart rate, motor activity and body temperature.

Authors:  J N Yang; Y Wang; P M Garcia-Roves; M Björnholm; B B Fredholm
Journal:  Acta Physiol (Oxf)       Date:  2010-02-01       Impact factor: 6.311

4.  Adenosine and the auditory system.

Authors:  Srdjan M Vlajkovic; Gary D Housley; Peter R Thorne
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

5.  NMDA receptor-mediated extracellular adenosine accumulation is blocked by phosphatase 1/2A inhibitors.

Authors:  Yin Lu; Paul A Rosenberg
Journal:  Brain Res       Date:  2007-05-04       Impact factor: 3.252

6.  Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade.

Authors:  Rodrigo A Cunha
Journal:  Purinergic Signal       Date:  2005-03-17       Impact factor: 3.765

7.  The role of ATP and adenosine in the brain under normoxic and ischemic conditions.

Authors:  F Pedata; A Melani; A M Pugliese; E Coppi; S Cipriani; C Traini
Journal:  Purinergic Signal       Date:  2007-10-11       Impact factor: 3.765

8.  Frequency facilitation at mossy fiber-CA3 synapses of freely behaving rats contributes to the induction of persistent LTD via an adenosine-A1 receptor-regulated mechanism.

Authors:  Hardy Hagena; Denise Manahan-Vaughan
Journal:  Cereb Cortex       Date:  2009-11-10       Impact factor: 5.357

9.  Basal adenosine modulates the functional properties of AMPA receptors in mouse hippocampal neurons through the activation of A1R A2AR and A3R.

Authors:  Silvia Di Angelantonio; Cristina Bertollini; Sonia Piccinin; Maria Rosito; Flavia Trettel; Francesca Pagani; Cristina Limatola; Davide Ragozzino
Journal:  Front Cell Neurosci       Date:  2015-10-12       Impact factor: 5.505

10.  3'-Deoxyadenosine (Cordycepin) Produces a Rapid and Robust Antidepressant Effect via Enhancing Prefrontal AMPA Receptor Signaling Pathway.

Authors:  Bai Li; Yangyang Hou; Ming Zhu; Hongkun Bao; Jun Nie; Grace Y Zhang; Liping Shan; Yao Yao; Kai Du; Hongju Yang; Meizhang Li; Bingrong Zheng; Xiufeng Xu; Chunjie Xiao; Jing Du
Journal:  Int J Neuropsychopharmacol       Date:  2016-04-20       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.